Spinal Cord Stimulation Market, Size, Share, Opportunities and Forecast, 2020-2027

SKU: DPH139 | Last Updated On: Apr 01 2020 | No. of Pages: 249 | Available Formats

> Global Spinal Cord Stimulation Market Expected to reach a high CAGR of 8.3% By 2027: DataM Intelligence

Global Spinal Cord Stimulation Market is segmented By Product Type (Implantable pulse generator, Rechargeable, Non-rechargeable, Radiofrequency system), By Disease Indication (Failed Back Syndrome (FBS), Degenerative Disk Disease (DDD), Complex Regional Pain Syndrome (CRPS), Arachnoiditis, Others), By End-user (Hospitals, Clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2020-2027

 

Market Overview

The Global Spinal Cord Stimulation Market is expected to grow at a CAGR of 8.3% during the forecasting period (2020-2027).
Neuromodulation is an emerging therapy involving targeted delivery of electromagnetic or chemical stimulation to a specific neurological area in the body. One of the neuromodulation technique is spinal cord stimulation which includes the delivery of electric stimuli to the spinal cord resulting in the masking of pain.

Market Overview

Source: DataM Intelligence Analysis (2019)

Market Dynamics

The major driving forces are the increasing geriatric population, new product launches by key companies, increasing number of patients suffering from spinal cord injuries, and favourable reimbursement and insurance approval policies. 

The increasing number of patients suffering from spinal cord injuries is expected to boost market growth over the forecast period. For instance, according to WHO, around the world, between 250,000 and 500,000 people suffer from spinal cord injury each year. The increasing incidence of spinal cord injuries, neurological disorders and chronic back pain are the factors that drive the growth of the market.

The rising geriatric population is expected to boost market growth. Many nations are facing challenges owing to the ongoing and the increasing demographic shift in age among the people. As per the Department of Economic and Social Affairs Population Division of United Nation, 2017, the world's population of 60 years will double and those of 80 years old will triple in the next 30 years. As per the World Health Organization, the number of people of 65 years or older is expected to increase to around 1.5 billion in 2050, with most of the increase in the developing countries. Thus, the increasing geriatric population, who are more prone to chronic illness like neurological disorders, are driving the market.

Moreover, the ongoing research and development in the spinal cord stimulation are expected to boost the market and able to serve more opportunities in the forecast period. For instance, according to an article published on October 3, 2019, supported with a new grant of $6.3 million from the US Defense Advanced Research Projects Agency, a team led by the Brown University researchers will develop and test an intelligent spinal interface aimed at helping to restore the limb movement and bladder control for people who have suffered spinal cord injuries. Also, according to an article published on February 1, 2019, spinal cord stimulation can restore voluntary movement and autonomic functions in paralyzed patients.

However, the high cost of devices, complications of spinal cord stimulator implantation, and stringent regulatory approvals will impede the growth of this market.

Complications of spinal cord stimulator implantation are expected to restrain market growth. For instance, according to the American Society of Regional Anesthesia and Pain Medicine (ASRA), complications, however, are estimated to range from 30%–40% and can be divided into two categories: device-related failure or biologic factors.

Further, according to the PriceGuide service, the average cost of the stimulators is $16,957. The newer models, manufactured by Boston Scientific Corporation and Medtronic, cost on average $19,000.

Market Segmentation

By product type, the spinal cord stimulation market can be segmented into the implantable pulse generator and radiofrequency system.

The implantable pulse generator is expected to grow at a high rate over the forecast period. It is further categorized into rechargeable and non-rechargeable.

The presence of an increased number of research and development activities is expected to propel market growth. For instance, according to an article published in 2017, new research has found spinal cord stimulation therapy can be vital in decreasing or stabilizing the use of opioids in the patients battling chronic pain. The researchers also examined opioid usage data from more than 5,400 patients both before and after receiving an SCS system implant. In this, an implanted device similar to a pacemaker delivers lower levels of electrical energy to the nerve fibres, interrupting pain signals as they travel to the brain to reduce the sensation of pain. Researchers also found that average daily opioid use declined or stabilized for the patients receiving a successful SCS system compared to the patient use of opioids before an implant.

The presence of funding for R&D activities is also expected to boost the market growth. For instance, according to an article published on October 23, 2019, a team from the Imperial College London and the Imperial College Healthcare NHS Trust have been awarded £250,000 from the Medical Research Council to trial a surgical implant that alters nerve activity, which could improve movement and reduce the number of falls.

Source: DataM Intelligence Analysis (2019)

By disease indication, the spinal cord stimulation market can be segmented into Failed Back Syndrome (FBS), Complex Regional Pain Syndrome (CRPS), Degenerative Disk Disease (DDD), Arachnoiditis, and Others.

The Failed Back Syndrome (FBS) segment is expected to grow at a high rate over the forecast period. The worldwide prevalence of the Failed Back Syndrome is growing, which is further generating demand for the development of new and effective therapies to treat chronic back pain.

Geographical Analysis

Geographically, the global spinal cord stimulation market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America is dominating the global spinal cord stimulation market in 2018 and is estimated to hold significant market size over the forecast period (2020-2027) owing to the emerging guidelines, favourable health reimbursements, increasing prevalence of spinal cord injuries.

The increasing prevalence of spinal cord injuries is expected to accelerate market growth. For instance, the most recent figures for the US alone, published in 2018 by the National Spinal Cord Injury Statistical Center, show that there are about 17,700 new SCI cases each year and an estimated 288,000 people with SCI currently living in the US. Also, more than 2.1 million people in the US suffer from substance abuse related to opioid pain relievers, while globally, an estimated 15.5 million people are now classified as opioid-dependent. Chronic pain is often a significant driver of opioid use as patients seek relief and improvement to their quality of life. Fortunately for patients, SCS therapy has been proven clinically to offer meaningful assistance to patients suffering from chronic pain.

The presence of an increased number of research and development activities in the region are expected to boost the market growth. For instance, according to an article published on November 8, 2019, the researchers of University of Wisconsin-Madison have published preclinical data from their collaboration to create externally powered neurostimulation systems by injecting fluid electrode material that cures in place. The project recently received a $2.1 million grant from a National Institutes of Health to support the development of a non-opioid alternative to treat chronic back pain. The injected stimulator elements would operate with power from a transcutaneous electrical stimulation unit.  Also, on November 5, 2019, an article about a chronic pain patient who recently found relief via spinal cord stimulation (SCS) notes that the government in British Columbia, Canada funds 28 SCS implants a year.

Source: DataM Intelligence Analysis (2019)

Competitive Landscape

The major players operating in the global spinal cord stimulation market are Medtronic, Abbott Laboratories, Boston Scientific Corporation, Nuvectra, Stimwave LLC, Saluda Medical Pty Ltd., Nevro Corporation, and Greatbatch.

The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, which are contributing to the growth of the spinal cord stimulation market globally. For instance,

On November 5, 2019, Nevro Corporation, announced it had received approval from the US FDA for the Senza Omnia Spinal Cord Stimulation (SCS) System. It is the first and only SCS system designed to deliver the Nevro's proprietary HF10 therapy in addition to all other available SCS systems.

On October 22, 2019, GTX medical BV (‘GTX’, formerly known as G-Therapeutics) and NeuroRecovery Technologies Inc. ('NRT') have merged to create a global company committed to developing new neuromodulation therapies to improve functional recovery of people with SCI.

On September 16, 2019, Saluda Medical Pty Limited ("Saluda Medical") announced the award of CE Mark and the European commercial launch of the Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for the treatment of chronic pain. The world's first commercial implants were completed in The Netherlands.

In June 2019, Boston acquired Vertiflex to add its spinal cord stimulation and radiofrequency ablation to its product portfolio.

In May 2019, Abbott teamed up with NIH in which Abbott will provide its brain stimulation (DBS), spinal cord stimulation (SCS), and dorsal root ganglion (DRG) therapy for research to NIH for chronic pain and progressive disorders.

In January 2019, Boston Scientific launched its Spectra WaveWriter spinal cord stimulator in Europe. It is used for the treatment of chronic pain through electrical impulses. This new system also allows physicians and patients to customize their therapy.

In 2019, Neuronoff, Inc., announced the award of a $2.2 million National Institutes of Health (NIH) grant to test its Injectrode, a novel injectable metal electrode, as an alternative means of treating chronic back pain.

In September 2017, Medtronic plc announced FDA approval and launch of the Intellis platform in the US for the management of certain types of chronic intractable pain. It was developed to overcome limitations with current spinal cord stimulation systems, like battery performance. It can power the EvolveSM workflow, which standardizes the guidance and balances high-dose and low-dose therapy settings.

Why Purchase the Report?

  • Visualize the composition of the global spinal cord stimulation market across each product type, disease indication, and end-user, highlighting the key commercial assets and players.
  • Identify commercial opportunities in the global spinal cord stimulation market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of the global spinal cord stimulation market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Type mapping in excel for the key Services of all major market players.

The Global Spinal Cord Stimulation Market report would provide access to an approx, 64 market data tables, 59 figures, and 220 pages.

Target Audience:

  • Equipment Suppliers/ Buyers
  • Type Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

 

Related Reports

Sacral Nerve Stimulation Market

Peripheral Nerve Stimulators Market

 

 

 

Table of Cont​​​​​​​ents

  1. Spinal Cord Stimulation Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Spinal Cord Stimulation Market – Market Definition and Overview

  3. Spinal Cord Stimulation Market – Executive Summary

    1. Market Snippet by Product type
    2. Market Snippet by Disease Indication
    3. Market Snippet by End-user
  4. Spinal Cord Stimulation Market Dynamics

    1. Market Impacting Factors
    2. Drivers
      1. The increasing number of patients with spinal cord injuries
      2. The ongoing research and development activities on spinal cord stimulation
    3. Restraints
      1. The complications of spinal cord stimulator implantation
    4. Opportunity
    5. Impact Analysis
  5. Spinal Cord Stimulation Market – Industry Analysis

    1. Porter's Five Forces Analysis
    2. Regulatory Analysis
    3. Supply Chain Analysis
    4. Pricing Analysis
    5. Unmet Needs
  6. Spinal Cord Stimulation Market - By Product type

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
      2. Market Attractiveness Index, By Product type Segment
    2. Implantable pulse generator*
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
    3. Rechargeable
    4. Non-rechargeable
    5. Radiofrequency system
  7. Spinal Cord Stimulation Market - By Disease Indication

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease indication
      2. Market Attractiveness Index, By Disease Indication Segment
    2. Failed Back Syndrome (FBS)*
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth
    3. Degenerative Disk Disease (DDD)
    4. Complex Regional Pain Syndrome (CRPS)
    5. Arachnoiditis
    6. Others
  8. Spinal Cord Stimulation Market - By End-user

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
      2. Market Attractiveness Index, By End-user Segment
    2. Hospitals *
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
    3. Clinics
    4. Others
  9. Spinal Cord Stimulation Market - By Region

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease indication
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. The U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease indication
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. The U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease indication
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease indication
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. The Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease indication
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
  10. Spinal Cord Stimulation Market Competitive Landscape

    1. Competitive Scenario
    2. Market Positioning/Share Analysis
    3. Mergers and Acquisitions Analysis
  11. Spinal Cord Stimulation Market Company Profiles

    1. Medtronic*
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Abbott Laboratories
    3. Boston Scientific Corporation
    4. Nuvectra
    5. Stimwave LLC
    6. Saluda Medical Pty Ltd.
    7. Nevro Corporation
    8. Greatbatch (List Not Exhaustive)
  12. Spinal Cord Stimulation Market – Premium Insights

  13. Spinal Cord Stimulation Market – Data-M

    1. Appendix
    2. About Us and Services
    3. Contact Us

List of Tables and Figures

LIST OF TABLES

TABLE 01 GLOBAL SPINAL CORD STIMULATION MARKET VALUE, BY PRODUCT TYPE, 2018, 2022 & 2026 ($ MILLION)

TABLE 02 GLOBAL SPINAL CORD STIMULATION MARKET VALUE, BY DISEASE INDICATION, 2018, 2022 & 2026 ($ MILLION)

TABLE 03 GLOBAL SPINAL CORD STIMULATION MARKET VALUE, BY END-USER, 2018, 2022 & 2026 ($ MILLION)

TABLE 04 GLOBAL SPINAL CORD STIMULATION MARKET VALUE, BY REGION, 2018, 2022 & 2026 ($ MILLION)

TABLE 05 GLOBAL SPINAL CORD STIMULATION MARKET VALUE, BY COUNTRY, 2018, 2022 & 2026 ($ MILLION)

TABLE 06 GLOBAL SPINAL CORD STIMULATION MARKET VALUE, BY PRODUCT TYPE, 2018, 2022 & 2026 ($ MILLION)

TABLE 07 GLOBAL SPINAL CORD STIMULATION MARKET VALUE, BY PRODUCT TYPE, 2017-2026 ($ MILLION)

TABLE 08 GLOBAL SPINAL CORD STIMULATION MARKET VALUE, BY DISEASE INDICATION, 2018, 2022 & 2026 ($ MILLION)

TABLE 09 GLOBAL SPINAL CORD STIMULATION MARKET VALUE, BY DISEASE INDICATION, 2017-2026 ($ MILLION)

TABLE 10 GLOBAL SPINAL CORD STIMULATION MARKET VALUE, BY END-USER, 2018, 2022 & 2026 ($ MILLION)

TABLE 11 GLOBAL SPINAL CORD STIMULATION MARKET VALUE, BY END-USER, 2017-2026 ($ MILLION)

TABLE 12 GLOBAL SPINAL CORD STIMULATION MARKET VALUE, BY REGION, 2018, 2022 & 2026 ($ MILLION)

TABLE 13 GLOBAL SPINAL CORD STIMULATION MARKET VALUE, BY REGION, 2017-2026 ($ MILLION)

TABLE 14 GLOBAL SPINAL CORD STIMULATION MARKET VALUE, BY COUNTRY, 2018, 2022 & 2026 ($ MILLION)

TABLE 15 GLOBAL SPINAL CORD STIMULATION MARKET VALUE, BY COUNTRY, 2017-2026 ($ MILLION)

TABLE 16 NORTH AMERICA SPINAL CORD STIMULATION MARKET VALUE, BY PRODUCT TYPE, 2017-2026 ($ MILLION)

TABLE 17 NORTH AMERICA SPINAL CORD STIMULATION MARKET VALUE, BY DISEASE INDICATION, 2017-2026 ($ MILLION)

TABLE 18 NORTH AMERICA SPINAL CORD STIMULATION MARKET VALUE, BY END-USER, 2017-2026 ($ MILLION)

TABLE 19 NORTH AMERICA SPINAL CORD STIMULATION MARKET VALUE, BY REGION, 2017-2026 ($ MILLION)

TABLE 20 NORTH AMERICA SPINAL CORD STIMULATION MARKET VALUE, BY COUNTRY, 2017-2026 ($ MILLION)

TABLE 21 SOUTH AMERICA SPINAL CORD STIMULATION MARKET VALUE, BY PRODUCT TYPE, 2017-2026 ($ MILLION)

TABLE 22 SOUTH AMERICA SPINAL CORD STIMULATION MARKET VALUE, BY DISEASE INDICATION, 2017-2026 ($ MILLION)

TABLE 23 SOUTH AMERICA SPINAL CORD STIMULATION MARKET VALUE, BY END-USER, 2017-2026 ($ MILLION)

TABLE 24 SOUTH AMERICA SPINAL CORD STIMULATION MARKET VALUE, BY REGION, 2017-2026 ($ MILLION)

TABLE 25 SOUTH AMERICA SPINAL CORD STIMULATION MARKET VALUE, BY COUNTRY, 2017-2026 ($ MILLION)

TABLE 26 EUROPE SPINAL CORD STIMULATION MARKET VALUE, BY PRODUCT TYPE, 2017-2026 ($ MILLION)

TABLE 27 EUROPE SPINAL CORD STIMULATION MARKET VALUE, BY DISEASE INDICATION, 2017-2026 ($ MILLION)

TABLE 28 EUROPE SPINAL CORD STIMULATION MARKET VALUE, BY END-USER, 2017-2026 ($ MILLION)

TABLE 29 EUROPE SPINAL CORD STIMULATION MARKET VALUE, BY REGION, 2017-2026 ($ MILLION)

TABLE 30 EUROPE SPINAL CORD STIMULATION MARKET VALUE, BY COUNTRY, 2017-2026 ($ MILLION)

TABLE 31 ASIA-PACIFIC SPINAL CORD STIMULATION MARKET VALUE, BY PRODUCT TYPE, 2017-2026 ($ MILLION)

TABLE 32 ASIA-PACIFIC SPINAL CORD STIMULATION MARKET VALUE, BY DISEASE INDICATION, 2017-2026 ($ MILLION)

TABLE 33 ASIA-PACIFIC SPINAL CORD STIMULATION MARKET VALUE, BY END-USER, 2017-2026 ($ MILLION)

TABLE 34 ASIA-PACIFIC SPINAL CORD STIMULATION MARKET VALUE, BY REGION, 2017-2026 ($ MILLION)

TABLE 35 ASIA-PACIFIC SPINAL CORD STIMULATION MARKET VALUE, BY COUNTRY, 2017-2026 ($ MILLION)

TABLE 36 MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET VALUE, BY PRODUCT TYPE, 2017-2026 ($ MILLION)

TABLE 37 MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET VALUE, BY DISEASE INDICATION, 2017-2026 ($ MILLION)

TABLE 38 MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET VALUE, BY END-USER, 2017-2026 ($ MILLION)

TABLE 39 MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET VALUE, BY REGION, 2017-2026 ($ MILLION)

TABLE 40 MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET VALUE, BY COUNTRY, 2017-2026 ($ MILLION)

TABLE 41 MEDTRONIC: OVERVIEW

TABLE 42 MEDTRONIC: PRODUCT PORTFOLIO

TABLE 43 MEDTRONIC: KEY DEVELOPMENTS

TABLE 44 ABBOTT LABORATOTRIES: OVERVIEW

TABLE 45 ABBOTT LABORATOTRIES: PRODUCT PORTFOLIO

TABLE 46 ABBOTT LABORATOTRIES: KEY DEVELOPMENTS

TABLE 47 BOSTON SCIENTIFIC CORPORATION: OVERVIEW

TABLE 48 BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO

TABLE 49 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS

TABLE 50 NUVECTRA: OVERVIEW

TABLE 51 NUVECTRA: PRODUCT PORTFOLIO

TABLE 52 NUVECTRA: KEY DEVELOPMENTS

TABLE 53 STIMWAVE LLC: OVERVIEW

TABLE 54 STIMWAVE LLC: PRODUCT PORTFOLIO

TABLE 55 STIMWAVE LLC: KEY DEVELOPMENTS

TABLE 56 SALUDA MEDICAL PTY LTD.: OVERVIEW

TABLE 57 SALUDA MEDICAL PTY LTD.: PRODUCT PORTFOLIO

TABLE 58 SALUDA MEDICAL PTY LTD.: KEY DEVELOPMENTS

TABLE 59 NEVRO CORPORATION: OVERVIEW

TABLE 60 NEVRO CORPORATION: PRODUCT PORTFOLIO

TABLE 61 NEVRO CORPORATION: KEY DEVELOPMENTS

TABLE 62 GREATBATCH: OVERVIEW

TABLE 63 GREATBATCH: PRODUCT PORTFOLIO

TABLE 64 GREATBATCH: KEY DEVELOPMENTS

 

 LIST OF FIGURES

FIGURE 01 GLOBAL SPINAL CORD STIMULATION MARKET SHARE, BY PRODUCT TYPE, 2018 & 2026 (%)

FIGURE 02 GLOBAL SPINAL CORD STIMULATION MARKET SHARE, BY DISEASE INDICATION, 2018 & 2026 (%)

FIGURE 03 GLOBAL SPINAL CORD STIMULATION MARKET SHARE, BY END-USER, 2018 & 2026 (%)

FIGURE 04 GLOBAL SPINAL CORD STIMULATION MARKET SHARE, BY REGION, 2018 & 2026 (%)

FIGURE 05 GLOBAL SPINAL CORD STIMULATION MARKET SHARE, BY COUNTRY, 2018 & 2026 (%)

FIGURE 06 GLOBAL SPINAL CORD STIMULATION MARKET VALUE, 2017-2026 ($ MILLION)

FIGURE 07 GLOBAL SPINAL CORD STIMULATION MARKET Y-O-Y GROWTH, BY PRODUCT TYPE, 2018-2026 (%)

FIGURE 08 IMPLANTABLE PULSE GENERATOR: GLOBAL SPINAL CORD STIMULATION MARKET VALUE, 2017-2026 ($ MILLION)

FIGURE 09 RADIO FREQUENCY SYSTEM: GLOBAL SPINAL CORD STIMULATION MARKET VALUE, 2017-2026 ($ MILLION)

FIGURE 10 GLOBAL SPINAL CORD STIMULATION MARKET Y-O-Y GROWTH, BY DISEASE INDICATION, 2018-2026 (%)

FIGURE 11 FAILED BACK SYNDROME (FBS): GLOBAL SPINAL CORD STIMULATION MARKET VALUE, 2017-2026 ($ MILLION)

FIGURE 12 DEGENERATIVE DISK DISEASE (DDD): GLOBAL SPINAL CORD STIMULATION MARKET VALUE, 2017-2026 ($ MILLION)

FIGURE 13 COMPLEX REGIONAL PAIN SYNDROME (CRPS): GLOBAL SPINAL CORD STIMULATION MARKET VALUE, 2017-2026 ($ MILLION)

FIGURE 14 ARACHNOIDITIS: GLOBAL SPINAL CORD STIMULATION MARKET VALUE, 2017-2026 ($ MILLION)

FIGURE 15 OTHERS: GLOBAL SPINAL CORD STIMULATION MARKET VALUE, 2017-2026 ($ MILLION)

FIGURE 16 GLOBAL SPINAL CORD STIMULATION MARKET Y-O-Y GROWTH, BY END-USER, 2018-2026 (%)

FIGURE 17 HOSPITALS: GLOBAL SPINAL CORD STIMULATION MARKET VALUE, 2017-2026 ($ MILLION)

FIGURE 18 CLINICS: GLOBAL SPINAL CORD STIMULATION MARKET VALUE, 2017-2026 ($ MILLION)

FIGURE 19 OTHERS: GLOBAL SPINAL CORD STIMULATION MARKET VALUE, 2017-2026 ($ MILLION)

FIGURE 20 GLOBAL SPINAL CORD STIMULATION MARKET Y-O-Y GROWTH, BY REGION, 2018-2026 (%)

FIGURE 21 GLOBAL SPINAL CORD STIMULATION MARKET Y-O-Y GROWTH, BY COUNTRY, 2018-2026 (%)

FIGURE 22 NORTH AMERICA SPINAL CORD STIMULATION MARKET VALUE, 2017-2026 ($ MILLION)

FIGURE 23 NORTH AMERICA SPINAL CORD STIMULATION MARKET SHARE, BY PRODUCT TYPE, 2018 & 2026 (%)

FIGURE 24 NORTH AMERICA SPINAL CORD STIMULATION MARKET SHARE, BY DISEASE INDICATION, 2018 & 2026 (%)

FIGURE 25 NORTH AMERICA SPINAL CORD STIMULATION MARKET SHARE, BY END-USER, 2018 & 2026 (%)

FIGURE 26 NORTH AMERICA SPINAL CORD STIMULATION MARKET SHARE, BY REGION, 2018 & 2026 (%)

FIGURE 27 NORTH AMERICA SPINAL CORD STIMULATION MARKET SHARE, BY COUNTRY, 2018 & 2026 (%)

FIGURE 28 SOUTH AMERICA SPINAL CORD STIMULATION MARKET VALUE, 2017-2026 ($ MILLION)

FIGURE 29 SOUTH AMERICA SPINAL CORD STIMULATION MARKET SHARE, BY PRODUCT TYPE, 2018 & 2026 (%)

FIGURE 30 SOUTH AMERICA SPINAL CORD STIMULATION MARKET SHARE, BY DISEASE INDICATION, 2018 & 2026 (%)

FIGURE 31 SOUTH AMERICA SPINAL CORD STIMULATION MARKET SHARE, BY END-USER, 2018 & 2026 (%)

FIGURE 32 SOUTH AMERICA SPINAL CORD STIMULATION MARKET SHARE, BY REGION, 2018 & 2026 (%)

FIGURE 33 SOUTH AMERICA SPINAL CORD STIMULATION MARKET SHARE, BY COUNTRY, 2018 & 2026 (%)

FIGURE 34 EUROPE SPINAL CORD STIMULATION MARKET VALUE, 2017-2026 ($ MILLION)

FIGURE 35 EUROPE SPINAL CORD STIMULATION MARKET SHARE, BY PRODUCT TYPE, 2018 & 2026 (%)

FIGURE 36 EUROPE SPINAL CORD STIMULATION MARKET SHARE, BY DISEASE INDICATION, 2018 & 2026 (%)

FIGURE 37 EUROPE SPINAL CORD STIMULATION MARKET SHARE, BY END-USER, 2018 & 2026 (%)

FIGURE 38 EUROPE SPINAL CORD STIMULATION MARKET SHARE, BY REGION, 2018 & 2026 (%)

FIGURE 39 EUROPE SPINAL CORD STIMULATION MARKET SHARE, BY COUNTRY, 2018 & 2026 (%)

FIGURE 40 ASIA-PACIFIC SPINAL CORD STIMULATION MARKET VALUE, 2017-2026 ($ MILLION)

FIGURE 41 ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SHARE, BY PRODUCT TYPE, 2018 & 2026 (%)

FIGURE 42 ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SHARE, BY DISEASE INDICATION, 2018 & 2026 (%)

FIGURE 43 ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SHARE, BY END-USER, 2018 & 2026 (%)

FIGURE 44 ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SHARE, BY REGION, 2018 & 2026 (%)

FIGURE 45 ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SHARE, BY COUNTRY, 2018 & 2026 (%)

FIGURE 46 MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET VALUE, 2017-2026 ($ MILLION)

FIGURE 47 MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SHARE, BY PRODUCT TYPE, 2018 & 2026 (%)

FIGURE 48 MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SHARE, BY DISEASE INDICATION, 2018 & 2026 (%)

FIGURE 49 MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SHARE, BY END-USER, 2018 & 2026 (%)

FIGURE 50 MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SHARE, BY REGION, 2018 & 2026 (%)

FIGURE 51 MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SHARE, BY COUNTRY, 2018 & 2026 (%)

FIGURE 52 MEDTRONIC: FINANCIALS

FIGURE 53 ABBOTT LABORATOTRIES: FINANCIALS

FIGURE 54 BOSTON SCIENTIFIC CORPORATION: FINANCIALS

FIGURE 55 NUVECTRA: FINANCIALS

FIGURE 56 STIMWAVE LLC: FINANCIALS

FIGURE 57 SALUDA MEDICAL PTY LTD.: FINANCIALS

FIGURE 58 NEVRO CORPORATION: FINANCIALS

FIGURE 59 GREATBATCH: FINANCIALS

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Get your FREE SAMPLE PROPOSAL with a single click!

linkedinpinterest